Hulse William Frank IV 4

What Happened William Frank Hulse IV, General Counsel and Chief Administrative Officer of MiMedx Group, converted/ exercised 136,364 derivative shares at $4.50 per share (total $613,638) on March 10, 2026. In connection with the vesting, 61,460 shares were reported as disposed/withheld at $4.50 per share to cover tax liabilities (value $276,570), leaving a net of 74,904 shares issued to him (136,364 acquired − 61,460 withheld). The primary activity was a vesting/conversion of performance stock units (PSUs) rather than an open-market purchase or independent sale.

Key Details

• Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (appears timely).
• Prices: $4.50 per share for both the conversion (code M) and the withholding/disposition (code F).
• Gross shares converted/acquired: 136,364 (value $613,638). Shares withheld/disposed for taxes: 61,460 (value $276,570). Net shares retained: 74,904.
• Footnotes: F1 — payout represents vesting of PSUs for the performance period Jan 1, 2023–Dec 31, 2025 (PSUs granted Mar 13, 2023). F2 — shares were withheld/sold per company policy to satisfy tax withholding upon vesting.
• Shares owned after the transaction were not included in the provided excerpt.

Context This was a routine equity compensation event: PSUs vested for the 2023–2025 performance period and converted into common shares, with shares withheld to pay required tax withholding (not an opportunistic market sale). Such withholding is standard and does not by itself indicate executive buying or selling sentiment. Transaction codes: M = exercise/conversion of derivative; F = shares withheld/paid to satisfy tax liability.